Immatics NV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015285941
  • NASDAQ: IMTX
USD
8.60
-0.27 (-3.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Geron Corp.
Deciphera Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc.
Relay Therapeutics, Inc.
Protagonist Therapeutics, Inc.
Tango Therapeutics, Inc.
Immatics NV
Arvinas, Inc.
Replimune Group, Inc.
Pliant Therapeutics, Inc.
Rayzebio, Inc.

Why is Immatics NV ?

1
The company has declared Negative results for the last 5 consecutive quarters
  • NET PROFIT(9M) At USD -181.93 MM has Grown at -101.73%
  • OPERATING CASH FLOW(Y) Lowest at USD -241.73 MM
  • NET SALES(HY) At USD 19.54 MM has Grown at -21.62%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 20.79%, its profits have fallen by -15839.9%
3
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -1.13% over the previous quarter and currently hold 4.5% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Immatics NV for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Immatics NV
20.79%
-0.55
60.62%
S&P 500
15.76%
1.20
13.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
15.89%
EBIT Growth (5y)
-211.68%
EBIT to Interest (avg)
-58.09
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.21
Tax Ratio
22.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
95.44%
ROCE (avg)
0
ROE (avg)
1.76%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.21
EV to EBIT
-3.34
EV to EBITDA
-3.58
EV to Capital Employed
34.42
EV to Sales
13.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1030.63%
ROE (Latest)
-39.59%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET PROFIT(HY)

Higher at USD -140.36 MM

NET SALES(Q)

At USD 10.63 MM has Grown at 98.02%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-17What is not working for the Company
NET PROFIT(9M)

At USD -181.93 MM has Grown at -101.73%

OPERATING CASH FLOW(Y)

Lowest at USD -241.73 MM

NET SALES(HY)

At USD 19.54 MM has Grown at -21.62%

ROCE(HY)

Lowest at -48.08%

OPERATING PROFIT(Q)

Lowest at USD -74.65 MM

Here's what is working for Immatics NV

Net Sales
At USD 10.63 MM has Grown at 98.02%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Net Profit
Higher at USD -140.36 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Immatics NV

Operating Cash Flow
Lowest at USD -241.73 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -74.65 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Footer loading